Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Aug 13, 2010

Premium

German biotech firm Scil Proteins announced this week the appointment of Andreas Menrad, Jurgen Wahl, and Ranier Kroell to its advisory board.

Menrad is vice president of antibody therapeutics at Genzyme's European research site in Cambridge, UK. Previously he was Genzyme's director of research and development and the director of antibody engineering and anti-angiogenesis research at Schering.

Wahl is the former head of biotech production at Roche where he worked for 22 years.

Kroell is the co-founder of GKK Partners, a Munich-based tax consultation and auditing firm.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.